We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.


The West Blog

Latest Post

March 12, 2018

Evolution in Biologic Drug Products – Need for Administration of High Viscosities

Biologic drug products are not new &ndash; their development began decades ago; the first monoclonal antibody was commercialized in 1986.<sup> [1]</sup> With the increasing availability of genetic information, and better understanding of subcellular cascades and disease processes, the number of biologic drug products available has increased substantially in response to an exponential growth in targets. <sup>[2]</sup>
Frederike Ferber

Frederike Ferber

Specialist, TCS, Commercial, EU

Subscribe to receive the latest blog post


Search the Blog





  • Previous Posts
    Pannel discussion at NIBRT

    March 14, 2017

    West and NIBRT Host Educational Event

    Brian Kenny

    Brian Kenny

    Director, Emerging Biotech, EMEA, Sales

    NovaPure 1 mL and 1-3 mL plungers

    February 06, 2017

    NovaPure® Plungers for Biologic Applications

    Christa Jansen-Otten

    Christa Jansen-Otten, Director, Product Management

    Petra Huhn, Manager, TCS Europe

    Subcutaneous Bilogics Pipeline Card

    October 11, 2016

    Important Concerns Regarding Volume and Viscosity Part 2

    Royce Brockett

    Royce Brockett

    Senior Product Manager